In need for a modern Daedalus? The challenging regulatory path for marketing gene therapy medicinal products in China and Europe
Résumé
This article highlights the regulatory challenges of the assessment process of Gene Therapy Medicinal Products. It also addresses the puzzling institutional maze that influences the regulatory path for the marketing of these products as shown through various examples in the European Union and in China.
Domaines
Droit
Fichier principal
Chapter- gene therapy China Europe- AM et al.pdf (190.51 Ko)
Télécharger le fichier
| Origine | Fichiers produits par l'(les) auteur(s) |
|---|